Roberto Aiolfi

898 total citations
16 papers, 698 citations indexed

About

Roberto Aiolfi is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Roberto Aiolfi has authored 16 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Roberto Aiolfi's work include Hepatitis C virus research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Immunotherapy and Immune Responses (3 papers). Roberto Aiolfi is often cited by papers focused on Hepatitis C virus research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Immunotherapy and Immune Responses (3 papers). Roberto Aiolfi collaborates with scholars based in United States, Italy and Netherlands. Roberto Aiolfi's co-authors include Giovanni Sitia, Luca G. Guidotti, Matteo Iannacone, Francis V. Chisari, Zaverio M. Ruggeri, Amleto Fiocchi, Marta Mainetti, Pietro Di Lucia, Antonio Esposito and Francesca Mingozzi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Roberto Aiolfi

14 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Aiolfi United States 7 281 264 252 156 80 16 698
Marta Mainetti Italy 3 235 0.8× 219 0.8× 217 0.9× 128 0.8× 61 0.8× 3 576
Amleto Fiocchi Italy 7 249 0.9× 241 0.9× 220 0.9× 158 1.0× 83 1.0× 7 630
Hui-Hua Hsiao Taiwan 10 256 0.9× 216 0.8× 140 0.6× 136 0.9× 83 1.0× 17 555
Jinpiao Lin China 14 270 1.0× 240 0.9× 110 0.4× 140 0.9× 194 2.4× 32 701
Zhongming Tan China 12 312 1.1× 250 0.9× 344 1.4× 177 1.1× 271 3.4× 24 914
Mirko Moreno Zaldivar Germany 9 427 1.5× 434 1.6× 191 0.8× 141 0.9× 151 1.9× 10 801
Sonja Hillebrandt Germany 9 318 1.1× 317 1.2× 187 0.7× 157 1.0× 130 1.6× 12 804
Orit Papo Israel 9 274 1.0× 215 0.8× 94 0.4× 70 0.4× 315 3.9× 12 765
Yufu Ye China 12 136 0.5× 130 0.5× 151 0.6× 155 1.0× 122 1.5× 26 516
Yun Zhuang China 14 112 0.4× 95 0.4× 113 0.4× 71 0.5× 146 1.8× 31 440

Countries citing papers authored by Roberto Aiolfi

Since Specialization
Citations

This map shows the geographic impact of Roberto Aiolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Aiolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Aiolfi more than expected).

Fields of papers citing papers by Roberto Aiolfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Aiolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Aiolfi. The network helps show where Roberto Aiolfi may publish in the future.

Co-authorship network of co-authors of Roberto Aiolfi

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Aiolfi. A scholar is included among the top collaborators of Roberto Aiolfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Aiolfi. Roberto Aiolfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Aiolfi, Roberto, José A. Fernández, Hiroshi Deguchi, et al.. (2023). Survival Advantage Associated with Heterozygous Factor V Leiden Mutation in Sars-Cov-2-Infected K18-hACE2 Mice. Blood. 142(Supplement 1). 2563–2563.
3.
Aiolfi, Roberto, et al.. (2022). Sex-Specific Differences in the Pathogenesis, Endothelial Dysfunction, and Hypercoagulability of Sars-Cov-2 Infection in K18-hACE2 Mice. Blood. 140(Supplement 1). 1674–1675. 3 indexed citations
4.
Aiolfi, Roberto, et al.. (2022). Arenaviral infection causes bleeding in mice due to reduced serotonin release from platelets. Science Signaling. 15(722). eabb0384–eabb0384. 2 indexed citations
5.
Aiolfi, Roberto, et al.. (2021). Sars-Cov-2 Infection Promotes Endothelial Dysfunction and Thrombosis in a Mouse Model of COVID-19. Blood. 138(Supplement 1). 999–999. 1 indexed citations
6.
Morodomi, Yosuke, Roberto Aiolfi, Sachiko Kanaji, et al.. (2019). Sca-1 As a Marker of Stress-Induced Thrombopoiesis in Mice. Blood. 134(Supplement_1). 1068–1068.
7.
Oldstone, Michael B. A., Brian C. Ware, Lucy E. Horton, et al.. (2018). Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics. Proceedings of the National Academy of Sciences. 115(33). E7814–E7823. 29 indexed citations
8.
Horton, Lucy E., Brian M. Sullivan, Robert F. Garry, et al.. (2017). Dysfunctional Platelet Aggregation in Patients with Acute Lassa Fever. Open Forum Infectious Diseases. 4(suppl_1). S223–S223. 1 indexed citations
9.
Catarinella, Mario, Giulia Escobar, Amleto Fiocchi, et al.. (2016). IFN α gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Molecular Medicine. 8(2). 155–170. 26 indexed citations
10.
Ricciardi, Sara, Annarita Miluzio, Daniela Brina, et al.. (2015). Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species‐dependent megakaryocyte maturation. Journal of Thrombosis and Haemostasis. 13(11). 2108–2118. 13 indexed citations
11.
Guidotti, Luca G., Donato Inverso, Laura Sironi, et al.. (2015). Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells. Cell. 161(3). 486–500. 239 indexed citations
12.
Aiolfi, Roberto & Giovanni Sitia. (2015). Chronic hepatitis B: role of anti-platelet therapy in inflammation control. Cellular and Molecular Immunology. 12(3). 264–268. 25 indexed citations
13.
Aiolfi, Roberto, et al.. (2014). Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Aiolfi, Roberto, et al.. (2014). Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma. Journal of Hepatocellular Carcinoma. 1. 183–183. 3 indexed citations
15.
Sitia, Giovanni, Roberto Aiolfi, Pietro Di Lucia, et al.. (2012). Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proceedings of the National Academy of Sciences. 109(32). E2165–72. 260 indexed citations
16.
Sitia, Giovanni, Matteo Iannacone, Roberto Aiolfi, et al.. (2011). Kupffer Cells Hasten Resolution of Liver Immunopathology in Mouse Models of Viral Hepatitis. PLoS Pathogens. 7(6). e1002061–e1002061. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Mainetti Breakdown of academic impact, for papers by Amleto Fiocchi Breakdown of academic impact, for papers by Hui-Hua Hsiao Breakdown of academic impact, for papers by Jinpiao Lin Breakdown of academic impact, for papers by Zhongming Tan Breakdown of academic impact, for papers by Mirko Moreno Zaldivar Breakdown of academic impact, for papers by Sonja Hillebrandt Breakdown of academic impact, for papers by Orit Papo Breakdown of academic impact, for papers by Yufu Ye Breakdown of academic impact, for papers by Yun Zhuang
Rankless by CCL
2026